BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dalla Via A, Gargari G, Taverniti V, Rondini G, Velardi I, Gambaro V, Visconti GL, De Vitis V, Gardana C, Ragg E, Pinto A, Riso P, Guglielmetti S. Urinary TMAO Levels Are Associated with the Taxonomic Composition of the Gut Microbiota and with the Choline TMA-Lyase Gene (cutC) Harbored by Enterobacteriaceae. Nutrients 2019;12:E62. [PMID: 31881690 DOI: 10.3390/nu12010062] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Coué M, Croyal M, Habib M, Castellano B, Aguesse A, Grit I, Gourdel M, Billard H, Lépine O, Michel C, Ouguerram K. Perinatal Administration of C-Phycocyanin Protects Against Atherosclerosis in apoE-Deficient Mice by Modulating Cholesterol and Trimethylamine-N-Oxide Metabolisms. Arterioscler Thromb Vasc Biol 2021;41:e512-23. [PMID: 34706557 DOI: 10.1161/ATVBAHA.121.316848] [Reference Citation Analysis]
2 Lee SJ, Park YS, Kim YJ, Han SU, Hwang GS, Han Y, Heo Y, Ha E, Ha TK. Changes in Trimethylamine-N-oxide Levels in Obese Patients following Laparoscopic Roux-en-Y Gastric Bypass or Sleeve Gastrectomy in a Korean Obesity Surgical Treatment Study (KOBESS). J Clin Med 2021;10:5091. [PMID: 34768610 DOI: 10.3390/jcm10215091] [Reference Citation Analysis]
3 Plaza-Diaz J. Nutrition, Microbiota and Noncommunicable Diseases. Nutrients 2020;12:E1971. [PMID: 32630712 DOI: 10.3390/nu12071971] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Li S, Wu D, Cao M, Yu Z, Wu M, Liu Y, Zhou J, Yan S, Chen J, Huang M, Zhao J. Effects of choline supplementation on liver biology, gut microbiota, and inflammation in Helicobacter pylori-infected mice. Life Sci 2020;259:118200. [PMID: 32758621 DOI: 10.1016/j.lfs.2020.118200] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
5 Gatarek P, Kaluzna-Czaplinska J. Trimethylamine N-oxide (TMAO) in human health. EXCLI J 2021;20:301-19. [PMID: 33746664 DOI: 10.17179/excli2020-3239] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
6 Liang X, Zhang Z, Lv Y, Tong L, Liu T, Yi H, Zhou X, Yu Z, Tian X, Cui Q, Yang J, Gong P, Zhang L. Reduction of intestinal trimethylamine by probiotics ameliorated lipid metabolic disorders associated with atherosclerosis. Nutrition 2020;79-80:110941. [PMID: 32858376 DOI: 10.1016/j.nut.2020.110941] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
7 Heng X, Liu W, Chu W. Identification of choline-degrading bacteria from healthy human feces and used for screening of trimethylamine (TMA)-lyase inhibitors. Microb Pathog 2021;152:104658. [PMID: 33253857 DOI: 10.1016/j.micpath.2020.104658] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Xie Z, Liu X, Huang X, Liu Q, Yang M, Huang D, Zhao P, Tian J, Wang X, Hou J. Remodelling of gut microbiota by Berberine attenuates trimethylamine N-oxide-induced platelet hyperreaction and thrombus formation. Eur J Pharmacol 2021;911:174526. [PMID: 34599914 DOI: 10.1016/j.ejphar.2021.174526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Coutinho-Wolino KS, de F Cardozo LFM, de Oliveira Leal V, Mafra D, Stockler-Pinto MB. Can diet modulate trimethylamine N-oxide (TMAO) production? What do we know so far? Eur J Nutr 2021. [PMID: 33533968 DOI: 10.1007/s00394-021-02491-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
10 Arias N, Arboleya S, Allison J, Kaliszewska A, Higarza SG, Gueimonde M, Arias JL. The Relationship between Choline Bioavailability from Diet, Intestinal Microbiota Composition, and Its Modulation of Human Diseases. Nutrients 2020;12:E2340. [PMID: 32764281 DOI: 10.3390/nu12082340] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
11 Liu F, Fan C, Zhang L, Li Y, Hou H, Ma Y, Fan J, Tan Y, Wu T, Jia S, Zhang Y. Alterations of Gut Microbiome in Tibetan Patients With Coronary Heart Disease. Front Cell Infect Microbiol 2020;10:373. [PMID: 32793515 DOI: 10.3389/fcimb.2020.00373] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
12 Zhuang Z, Li N, Wang J, Yang R, Wang W, Liu Z, Huang T. GWAS-associated bacteria and their metabolites appear to be causally related to the development of inflammatory bowel disease. Eur J Clin Nutr. [DOI: 10.1038/s41430-022-01074-w] [Reference Citation Analysis]
13 Goh YQ, Cheam G, Wang Y. Understanding Choline Bioavailability and Utilization: First Step Toward Personalizing Choline Nutrition. J Agric Food Chem 2021. [PMID: 34392687 DOI: 10.1021/acs.jafc.1c03077] [Reference Citation Analysis]
14 Dietert RR. Microbiome First Medicine in Health and Safety. Biomedicines 2021;9:1099. [PMID: 34572284 DOI: 10.3390/biomedicines9091099] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
15 Linz B, Saljic A, Hohl M, Gawałko M, Jespersen T, Sanders P, Böhm M, Linz D. Inhibition of sodium-proton-exchanger subtype 3-mediated sodium absorption in the gut: A new antihypertensive concept. Int J Cardiol Heart Vasc 2020;29:100591. [PMID: 32760780 DOI: 10.1016/j.ijcha.2020.100591] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]